Clinical Coagulation, Malmö
521 – 530 of 631
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
(
- Contribution to journal › Article
-
Mark
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
(
- Contribution to journal › Article
-
Mark
Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults.
(
- Contribution to journal › Article
-
Mark
Familial thrombophilia and lifetime risk of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
(
- Contribution to journal › Article
-
Mark
Hereditary thrombophilia and fetal loss: a prospective follow-up study
(
- Contribution to journal › Article
-
Mark
Economic evaluation: what are we looking for and how do we get there?
(
- Contribution to journal › Article
-
Mark
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
(
- Contribution to journal › Article
-
Mark
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
(
- Contribution to journal › Article
-
Mark
Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities
(
- Contribution to journal › Article